Today: 21 July 2026
Browse Category

IPO News 16 December 2025 - 31 December 2025

National Stock Exchange of India (NSE) Outlook: Nifty 50 Holds Near Record Highs as Year-End Data, F&O Expiry and IPO Buzz Take Center Stage

National Stock Exchange of India (NSE) Outlook: Nifty 50 Holds Near Record Highs as Year-End Data, F&O Expiry and IPO Buzz Take Center Stage

India’s National Stock Exchange is shut for the weekend, but the conversation around Dalal Street isn’t taking a day off. After a soft finish on Friday, the Nifty 50 is still hovering near record territory, and the next session’s tone is likely to be set by a familiar year-end cocktail: thin liquidity, foreign flows, macroeconomic data releases, and a calendar that’s about to flip to 2026.
28 December 2025
··
Shanghai Stock Exchange Outlook: China’s 2026 Fiscal Signal, Yuan Strength, and STAR Market IPO Changes Set the Tone for the Next Session

Shanghai Stock Exchange Outlook: China’s 2026 Fiscal Signal, Yuan Strength, and STAR Market IPO Changes Set the Tone for the Next Session

The Shanghai Stock Exchange heads into the final stretch of the year with momentum still intact—but with a growing “show me the earnings” demand from investors as policy headlines and macro data collide. The benchmark Shanghai Composite ended Friday at 3,963.68, up 0.1%, with combined turnover across Shanghai and Shenzhen totaling about 2.16 trillion yuan, as gains in themes such as commercial spaceflight and lithium batteries helped offset weakness elsewhere. Xinhua News
28 December 2025
···
Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

Medtronic plc heads into the weekend with investors balancing a quiet, year-end tape against several company-specific narratives that still matter for 2026: a freshly passed dividend record window, the planned separation of its diabetes business via the MiniMed IPO process, and continued focus on cardiovascular momentum that has helped drive the stock’s 2025 run.
27 December 2025
···
Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

December 22, 2025 — Barrick Mining Corporation stock is ending the year with a rare triple tailwind: a fresh record in gold prices, a major geopolitical overhang easing in Mali, and an ongoing strategic shake-up that could materially change how the market values the company’s North American assets.
22 December 2025
···
National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

Mumbai/Bengaluru — December 21, 2025 — The National Stock Exchange of India is ending 2025 in a situation that would have sounded contradictory a few years ago: India is home to one of the biggest derivatives machines on Earth, yet the country’s flagship equity market is behaving like it’s on sedatives. Options traders are being forced to rethink playbooks, regulators are still tightening the screws on speculation, and the exchange itself remains in the spotlight for a long-awaited IPO that’s still gated by settlements and governance clean-up.
21 December 2025
·
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology stocks head into the Christmas-shortened trading week with fresh momentum—and plenty for investors to digest—after a dense run of catalysts between December 19 and December 21, 2025. In the span of 48 hours, the sector saw a major rare-disease acquisition, a closely watched FDA approval in cardiology, IPO paperwork from both biotech and medtech, and a sweeping wave of U.S. drug-pricing headlines that could reshape sentiment into 2026. Investopedia+4Reuters+4Reuters+4
21 December 2025
·····
Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Ltd heads into the final stretch of 2025 with its stock trading close to a fresh 52-week peak—powered by a familiar Reliance cocktail: strong refining economics, rising confidence in consumer-facing cash flows, and a growing “value-unlocking” narrative around Jio. LiveMint+2Investing.com+2
21 December 2025
····
Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

NEW YORK, Dec. 19, 2025 — Morgan Stanley stock traded higher Friday as investors weighed a cluster of catalysts: a Reuters report that the bank is emerging as a leading candidate to help run a potential SpaceX initial public offering, a drumbeat of upbeat industry outlooks for 2026 dealmaking, and a growing focus on Morgan Stanley’s upcoming fourth-quarter results in mid-January. Reuters+2Nasdaq+2
19 December 2025
···
Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

December 19, 2025 — Navan, Inc. stock is sharply higher in Friday trading, putting the newly public corporate travel-and-expense platform back on traders’ screens just days after its debut earnings report triggered a steep selloff. The immediate catalyst: a notable open-market insider purchase disclosed in an SEC filing, which helped shift the day’s narrative from “post‑earnings pain” to “insider conviction.” SEC+1
19 December 2025
···
Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Updated: December 18, 2025 — Gujarat Kidney and Super Speciality Ltd has finalised the price band for its upcoming mainboard IPO, setting the stage for a ₹251 crore public issue that will open next week. The offer is entirely a fresh issue—meaning the company will receive the proceeds—at a time when investors are tracking healthcare listings closely for both growth visibility and execution risks. The Economic Times+1
18 December 2025
·
Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

The Nasdaq Stock Market closed sharply lower on Wednesday as renewed anxiety around the “AI trade” hit megacap technology and chip leaders, sending the Nasdaq Composite down 418.14 points to 22,693.32—a three-week low—despite a headline-grabbing IPO debut on the exchange and a late-day after-hours surge in Micron following blockbuster guidance. Reuters+2AP News+2
17 December 2025
····
Meesho Limited Stock Jumps to Upper Circuit on Dec 17, 2025: UBS “Buy” Call, ₹220 Target, and What’s Next for Meesho Shares After the IPO

Meesho Limited Stock Jumps to Upper Circuit on Dec 17, 2025: UBS “Buy” Call, ₹220 Target, and What’s Next for Meesho Shares After the IPO

Meesho Limited shares surged sharply on December 17, 2025, hitting the 20% upper circuit and printing fresh record highs in early trade—an eye-catching move for a company that listed barely a week ago. The spark: a bullish UBS initiation that put a ₹220 target on the newly listed e-commerce stock, amplifying a rally that has already taken Meesho close to double its IPO issue price. Moneycontrol+2The Economic Times+2
17 December 2025
···
Reliance Industries Share Price Today (16 December 2025): RIL Stock in Focus on AI Unit Launch, Jio IPO Signals; Analyst Targets Cluster Around ₹1,700+

Reliance Industries Share Price Today (16 December 2025): RIL Stock in Focus on AI Unit Launch, Jio IPO Signals; Analyst Targets Cluster Around ₹1,700+

Mumbai, December 16, 2025 — Reliance Industries Limited shares were trading around ₹1,544 on Tuesday, down about 0.7%–0.8% intraday, as broader markets slipped under the weight of a weaker rupee and continued foreign selling pressure. The stock moved in a relatively tight band in early-to-mid trade, with an intraday range of roughly ₹1,539–₹1,552 and a 52-week range of ₹1,114.85–₹1,581.30, keeping it within striking distance of the year’s high even on a soft tape. Moneycontrol+1
16 December 2025
···
1 … 3 4 5 6 7 8
Go toTop